Format

Send to

Choose Destination
Nat Rev Drug Discov. 2009 Feb;8(2):129-38. doi: 10.1038/nrd2742.

Knocking down barriers: advances in siRNA delivery.

Author information

1
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.

Erratum in

  • Nat Rev Drug Discov. 2009 Jun;8(6):516.

Abstract

In the 10 years that have passed since the Nobel prize-winning discovery of RNA interference (RNAi), billions of dollars have been invested in the therapeutic application of gene silencing in humans. Today, there are promising data from ongoing clinical trials for the treatment of age-related macular degeneration and respiratory syncytial virus. Despite these early successes, however, the widespread use of RNAi therapeutics for disease prevention and treatment requires the development of clinically suitable, safe and effective drug delivery vehicles. Here, we provide an update on the progress of RNAi therapeutics and highlight novel synthetic materials for the encapsulation and intracellular delivery of nucleic acids.

PMID:
19180106
PMCID:
PMC7097568
DOI:
10.1038/nrd2742
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center